Informa (INF) H2 2016 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2016 earnings summary
23 Oct, 2026Executive summary
2016 organic revenue growth was 1.6%; reported revenue rose 11%, aided by acquisitions and U.S. dollar strength.
Adjusted operating profit increased 13.8%; adjusted earnings were 42.1p, up 6.6% YoY on a rights-issue-restated 2015 basis.
Growth Acceleration Plan investment peaked in 2016; management cited product launches and capability improvements as supports for growth from 2017.
Financial highlights
Adjusted operating profit margin rose 70 bps to 30.9%, supported by the increasing mix of higher-margin Global Exhibitions.
Free cash flow was £306m, slightly higher YoY, despite almost £20m of additional CapEx investment.
Full-year dividend increased 4.3% to 19.3p per share; dividend cover was 2.2x earnings.
Return on capital employed was 9.2%, unchanged from 2015, despite peak plan investment and pension additions.
Outlook and guidance
2017 guidance targets growth in revenue, earnings, dividends and cash; free cash flow target exceeds £400m.
2017 adjusted tax rate expected at 21.5%, up from 18% in 2016; acquired tax losses partly mitigate cash tax impact.
At least half of Penton’s £14m synergy target expected in 2017; 2017 Penton revenue expected to be broadly flat, perhaps slightly down.
Post-plan ambition is for all divisions to be growing entering 2018; management described group organic growth potential as 2%–3%, without a specific timetable to exceed 3%.
Ongoing CapEx expected at 3%–5% of revenue, focused particularly on IT infrastructure, platforms and product delivery in Academic Publishing and BI.
Latest events from Informa
- Global pharma events pair supply-chain reach with data-led growth opportunities.INF
Investor presentation - 9M revenue grew 6.5%; double-digit adjusted EPS growth guidance was reaffirmed.INF
Q3 2026 TU - Resilient subscriptions and cost actions anchor a £1.7bn FY21 transition-year baseline.INF
H2 2020 - Strong 2019 cash generation met COVID-19 disruption with ~£450m of events rescheduled.INF
H2 2019 - Underlying growth reached 3.7% as UBM integration advanced and synergies set up 2019.INF
H2 2018 - Strong cash generation and rising dividends funded a measured growth and portfolio reset.INF
H2 2014 - Record 26.4% operating margin, strong cash generation and lower debt marked FY2011.INF
H2 2011 - Revenue rose 30.7%, underlying growth accelerated, and 2018 growth target topped 3.5%.INF
H2 2017 - 10.1% five-month growth, a £0.5bn buyback and a Q4 2024 TechTarget target.INF
AGM 2024 & Trading update